Joslin Study Shows Durability of Insulin Pump Therapy for Adolescents and Identifies Factors to Help Them Overcome Barriers to Success :
BOSTON — October 31, 2006 — In spite of its many advantages, there are many challenges to using an insulin pump to treat type 1 diabetes. Despite these challenges, however, more and more youngsters are choosing pump therapy, even though important questions remain about the pump’s effectiveness for this age group: With all its risks and demands, is it a method of treatment that children and teens can maintain? What causes adolescents to go off of pump therapy and how often does this occur? Is it possible to identify those youth unable to meet the demands of pump therapy and to find interventions that will help them succeed?
Joslin Diabetes Center Awards Victory Medal to New York Man Living 75 Years with Type 1 Diabetes :
BOSTON — August 9, 2006 — Joslin Diabetes Center, the global leader in diabetes research, care and education, will present its 22nd Joslin Victory Award Medal this Sunday, Aug. 13, to a New York man for living 75 years with type 1 (insulin-dependent) diabetes. Robert L. Bates of New Windsor, NY, will be awarded the medal at his 80th birthday celebration at the Thayer Hotel at West Point, NY. The hotel coincidentally is commemorating its 80th anniversary.
WGBH's Popular “Arthur” Show Lends Support to Diabetes Awareness :
BOSTON — May 15, 2006 — “And now a word from us kids!” is a familiar line for anyone who has ever seen the popular animated series Arthur produced by WGBH Boston and Cookie Jar Entertainment that airs daily on PBS KIDS GO! And on May 17, those words will introduce a segment about healthy eating and diabetes management featuring 11-year-old Corinne, a patient with type 1 diabetes at Joslin Diabetes Center.
Joslin Diabetes Center Partners with St. John Health in Michigan :
BOSTON — May 9, 2006 — Joslin Diabetes Center, the global leader in diabetes research, care and education, has announced its partnership with Providence Hospital in Southfield, Mich., and St. John Providence Park Hospital in Novi, Mich. The Joslin Diabetes Center Affiliate, which opened April 10, offers the latest advances for treating diabetes and its complications as well as patient education and support services.
Joslin Diabetes Center-Led Study Reveals New Findings on How Insulin-Producing Beta Cells Grow and Function:
BOSTON—April 23, 2006—A new Joslin Diabetes Center-led study has shown conclusively that two receptors in the insulin-producing beta cell do not affect developmental growth, refuting a long-held hypothesis in diabetes research. This finding is helping scientists in their efforts to isolate the growth factors that do stimulate beta cell growth and understand the defects in insulin production and secretion that cause diabetes.
Big Hips, Big Belly? It's in Your Genes :
BOSTON — April 10, 2006 — Do you have big hips or a "beer" belly? Are you "apple-shaped" or "pear-shaped"? It makes a difference, since we know that abdominal obesity is linked to diabetes and many other metabolic conditions, such as the metabolic syndrome. What's new is that, according to a new study led by researchers at Joslin Diabetes Center in Boston, both obesity and body shape seem to be controlled by important genes that are part of the mechanisms regulating normal development.
Joslin’s Annual Teddy Bear Clinic Set For Saturday, April 8 :
BOSTON – March 31, 2006 – More than 100 children and their families are expected to attend Joslin Diabetes Center’s Annual Teddy Bear Clinic on Saturday, April 8 from 1-3 p.m. in the 2nd floor Atrium at Joslin Diabetes Center. Joslin is located near the corner of Brookline and Longwood Avenues in Boston’s Longwood Medical Area.
Joslin Researchers Reveal Mechanisms Behind A Class of Oral Agents Used to Treat Type 2 Diabetes:
BOSTON — March 9, 2006 — Thiazolidinediones (TZD's) are drugs commonly prescribed to patients with type 2 diabetes, the most common form of diabetes. Current U.S. Food and Drug Administration-approved agents are known as Actos (pioglitazone) and Avandia (rosiglitazone). These oral agents improve blood glucose levels in people with diabetes by improving insulin action in the body.
Study Using New Imaging Technology Detects Subtle Brain Changes in Patients with Type 1 Diabetes:
BOSTON — January 31, 2006 — Although people with diabetes are twice as likely as the general population to develop depression, the cause of this increased risk is not well understood. Now, a Joslin Diabetes Center-led collaboration has documented for the first time subtle changes in the gray matter of the brain of type 1 diabetes patients compared to control subjects who did not have diabetes.